|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,170.50 INR | +1.89% |
|
-2.28% | +5.97% |
| 13/06 | Jubilant Pharmova to Transfer API Business to Subsidiary Jubilant Biosys | MT |
| 13/06 | Jubilant Enpro, Nikita Resources Sell 4.1 Million Shares In Jubilant Pharmova Via Bulk Deals Per NSE Data | RE |
| Capitalization | 19TCr 216.28Cr 184.77Cr 172.26Cr 159.31Cr 295.39Cr 328.25Cr 2.05TCr 785.29Cr 8.68TCr 811.15Cr 794.2Cr 32TCr | P/E ratio 2025 * |
-
| P/E ratio 2026 * | 33x |
|---|---|---|---|---|---|
| Enterprise value | 19TCr 216.28Cr 184.77Cr 172.26Cr 159.31Cr 295.39Cr 328.25Cr 2.05TCr 785.29Cr 8.68TCr 811.15Cr 794.2Cr 32TCr | EV / Sales 2025 |
1.95x | EV / Sales 2026 * | 2.35x |
| Free-Float |
35.51% | Yield 2025 |
0.56% | Yield 2026 * | 0.43% |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | +1.89% | ||
| 1 week | -2.28% | ||
| Current month | -3.20% | ||
| 1 month | +2.37% | ||
| 3 months | +41.39% | ||
| 6 months | +16.71% | ||
| Current year | +5.97% |
| 1 week | 1,145 |  | 1,232.85 |
| 1 month | 1,060.5 | | 1,232.85 |
| Current year | 823.7 | | 1,232.85 |
| 1 year | 701.4 | | 1,309 |
| 3 years | 268.8 | | 1,309 |
| 5 years | 268.8 | | 1,309 |
| 10 years | 195 | | 1,309 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 38 | 01/06/2023 | |
| Chief Executive Officer | 48 | 01/06/2023 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 53 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 21/07/1978 | |
| Chairman | 68 | 02/08/2012 | |
| Director/Board Member | 75 | 23/05/2017 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 89 M€ | +0.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.89% | -2.28% | +60.12% | +223.39% | 212.2Cr | ||
| +0.47% | +1.46% | -15.21% | +139.25% | 71TCr | ||
| +0.90% | +1.37% | +7.24% | -11.55% | 38TCr | ||
| +2.30% | +2.23% | +16.04% | +27.58% | 34TCr | ||
| +2.82% | +3.18% | -52.84% | +14.03% | 31TCr | ||
| +1.15% | +1.11% | +7.52% | -18.30% | 26TCr | ||
| +1.70% | +0.79% | +2.18% | +19.88% | 24TCr | ||
| +2.55% | +2.27% | -11.03% | -3.78% | 22TCr | ||
| +0.37% | +1.98% | -33.34% | -9.44% | 21TCr | ||
| +1.30% | +1.19% | -4.92% | +20.88% | 16TCr | ||
| Average | +1.04% | +0.21% | -2.42% | +40.19% | 28.2TCr | |
| Weighted average by Cap. | +0.77% | +0.43% | -9.40% | +38.52% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 7.23TCr 84Cr 72Cr 67Cr 62Cr 115.22Cr 128.04Cr 801.15Cr 306.32Cr 3.39TCr 316.4Cr 309.79Cr 12TCr | 7.88TCr 92Cr 79Cr 73Cr 68Cr 125.63Cr 139.61Cr 873.5Cr 333.98Cr 3.69TCr 344.98Cr 337.77Cr 13TCr |
| Net income | 821.2Cr 9.58Cr 8.19Cr 7.63Cr 7.06Cr 13Cr 15Cr 91Cr 35Cr 384.54Cr 36Cr 35Cr 1.4TCr | 565.5Cr 6.6Cr 5.64Cr 5.26Cr 4.86Cr 9.01Cr 10Cr 63Cr 24Cr 264.81Cr 25Cr 24Cr 965.13Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,399
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/25/10 | 1,170.50 ₹ | +1.89% | 4,432 |
| 09/25/09 | 1,148.75 ₹ | -1.49% | 9,147 |
| 08/25/08 | 1,166.15 ₹ | -2.81% | 14,767 |
| 07/25/07 | 1,199.85 ₹ | +0.28% | 14,889 |
| 04/25/04 | 1,196.50 ₹ | -0.45% | 8,117 |
Delayed Quote Bombay S.E., July 10, 2025 at 03:30 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,170.50INR
Average target price
1,299.50INR
Spread / Average Target
+11.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- JUBLPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition